Leflunomide termination rates in comparison with others DMARDs in rheumatoid arthritis.

被引：0
|
作者：
Brault, I [1 ]
Gossec, L [1 ]
Pham, T [1 ]
Dougados, M [1 ]
机构：
[1] Univ Paris 05, Cochin Hosp, Paris, France
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S540 / S541
页数：2
相关论文
共 50 条
  • [1] Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDs
    Bettembourg-Brault, I.
    Gossec, L.
    Pham, T.
    Gottenberg, J. -E.
    Damiano, J.
    Dougados, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (02) : 168 - 171
  • [2] Comparison of the effectiveness of commonly used DMARDs in rheumatoid arthritis.
    Malinowski, J
    Sibley, J
    Pahwa, P
    Nair, B
    Dyck, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S399 - S399
  • [3] Is leflunomide as safe and effective in the treatment of rheumatoid arthritis as other DMARDs?
    Schooff, M
    Wickersham, J
    AMERICAN FAMILY PHYSICIAN, 2003, 68 (05) : 849 - 850
  • [4] A comparison of the renal effects of leflunomide, methotrexate, and sulfasalazine during treatment of rheumatoid arthritis.
    Schiff, M
    Whelton, A
    Strand, V
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S351 - S351
  • [5] Rates of infection in rheumatoid arthritis.
    Smitten, A
    Simon, T
    Hochberg, M
    Suissa, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S478 - S479
  • [6] A meta-analysis of treatment termination rates on parenteral gold and methotrexate in rheumatoid arthritis.
    Maetzel, A
    Bombardier, C
    Strand, V
    Tugwell, P
    Wells, G
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1693 - 1693
  • [7] Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation
    van Roon, EN
    Hoekstra, M
    Tobi, H
    Jansen, TLTA
    Bernelot Moens, HJ
    Brouwers, JRBJ
    van de Laar, MAFJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (03) : 319 - 325
  • [8] Estimates of functional disability averted by leflunomide treatment in rheumatoid arthritis.
    Fries, JF
    Krishnan, E
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S539 - S539
  • [9] Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis.
    Tak, PP
    Kraan, MC
    Smeets, TJM
    van Loon, MJ
    Breedveld, FC
    Dijkmans, BAC
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S136 - S136
  • [10] Rates of herpes zoster in rheumatoid arthritis.
    Smitten, A
    Simon, T
    Suissa, S
    Hochberg, M
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S556 - S557
12345